Toward a Framework to Improve Diversity and Inclusion in Clinical Trials

by National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, National Cancer Policy Forum, Forum on Drug Discovery, Development, and Translation